Atigliflozin | MedChemExpress (MCE)
Atigliflozin (AVE-2268) is an orally active and selective SGLT-2 inhibitor, with IC50s of 10 nM and 8.2 μM for hSGLT-2 and hSGLT-1) respectively. Atigliflozin can lower the blood glucose and improve the impaired oral glucose tolerance. Atigliflozin can be used for research of type II diabetes mellitus[1].
| Trivial name | Atigliflozin |
| Catalog Number | HY-14810 |
| Alternative Name(s) | AVE-2268 |
| Research Area | Metabolic Disease |
| CAS# | 647834-15-9 |
| Purity | ≥98.0% |
| SMILES | O[C@H]1[C@H](OC2=C(CC3=CC=C(OC)C=C3)SC=C2)O[C@H](CO)[C@@H](O)[C@@H]1O |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/atigliflozin.html |